Clinical trial
MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis Patients
NCT01959165 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MEDI7183 Phase 2 Study in Japanese Ulcerative Colitis Patients
- Lead sponsor
- AstraZeneca
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 21, 2013
- Completion date
- April 10, 2018
- Enrollment
- 44 (actual)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.
ulcerative colitis